Korean J Helicobacter Up Gastrointest Res.
2012 Dec;12(4):219-223. 10.7704/kjhugr.2012.12.4.219.
Recent Trends of Helicobacter pylori Eradication Therapy in Korea
- Affiliations
-
- 1Division of Gastroenterology, Incheon St. Mary's Hospital, Department of Internal Medicine, The Catholic University of Korea, College of Medicine, Incheon, Korea. gastro@catholic.ac.kr
- KMID: 2143406
- DOI: http://doi.org/10.7704/kjhugr.2012.12.4.219
Abstract
- Helicobacter pylori infection is one of the most common gastrointestinal infectious diseases in Korea and is related to diseases such as gastritis, peptic ulcer disease, marginal zone B cell lymphoma of mucosa-associated lymphoid tissue type, and gastric adenocarcinoma. The eradication of H. pylori infection requires combinations of antibiotics and acid suppressants. Triple therapy has been considered as the first-line therapy for a long time. However, its eradication rate is declining and we need more effective strategies. Quadruple therapy including acid suppressants, bismuth, and other two antibiotics is a main rescue therapy after first-line therapy failure in Korea. In this review, we describe new therapeutic regimens and new trends of H. pylori eradication in Korea.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Recent Trends of Helicobacter pylori Eradication Therapy: Focusing on First Line Treatment
- Approach to Patients after Successful Eradication of Helicobacter pylori
- Changes in the Eradication Rate of Conventional Triple Therapy for Helicobacter pylori Infection in Korea
- Helicobacter pylori Eradication and Gastric Cancer Prevention
- Treatment of Helicobacter pylori infection in functional dyspepsia
